OrbusNeich Medical Group Holdings Limited (FRA:Q8T)

Market Cap	358.06M +8.4%
Revenue (ttm)	153.69M +10.0%
Net Income	35.69M +5.5%
EPS	0.04 +5.6%
Shares Out	n/a
PE Ratio	10.03
Forward PE	9.36
Dividend	0.03 (7.81%)
Ex-Dividend Date	Jun 10, 2026

Volume	n/a
Open	0.3660
Previous Close	0.3780
Day's Range	0.3660 - 0.3660
52-Week Range	0.2940 - 0.6550
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About FRA:Q8T

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents. Its ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2001
• Employees: 1,477
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: Q8T

Financial Performance

In 2025, FRA:Q8T's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error